Wednesday 6 March 2013

Colorectal Cancer Health Center


In average-risk people, screening colonoscopies were associated with a 70 percent reduction in risk for new, late-stage colon cancer, including hard-to-detect cancers on the right side of the colon. Advanced colon cancer is the least curable form.
Although colonoscopy is widely used as a screening test for colon cancer, there is little research that proves it is effective in reducing colon cancer deaths, according to the study authors. The researchers wanted to answer a simple question: If you ended up with late-stage cancer, were you more or less likely to have had a screening colonoscopy as many as 10 years before the disease was discovered?
The study authors also wanted to show whether a colonoscopy is able to evaluate the entire colon, including the right side, which is harder to adequately cleanse before the test, more difficult to reach, and often has pre-cancerous areas that are tougher to spot and identify.
"Colonoscopy has the ability to identify both left- and right-sided colon cancers before they have progressed to an advanced stage," said lead study author Dr. Chyke Doubeni, associate professor in the department of family medicine at the University of Pennsylvania.
The researchers also discovered that screening sigmoidoscopy, a less costly procedure that enables a physician to look at the part of the large intestine closest to the rectum, was linked to a significant reduction in late-stage disease in most of the large intestine, but not in the right colon.
However, the study does not show that colonoscopy or sigmoidoscopy is better than the much easier, far less expensive "fecal occult blood test" (FOBT), which is done at home by swiping a tiny amount of stool onto a card for three days, said Doubeni. "There is strong evidence showing the effectiveness of the [fecal occult blood test] when done annually. There is no reason, based on the knowledge we currently have, that you should switch to a colonoscopy if you're getting a FOBT every year," said Doubeni.
If simpler tests are effective, why are patients encouraged to undergo a colonoscopy? "Let me just say there are other factors beyond the evidence that are driving the use of colonoscopy in the U.S.," said Doubeni. "No other country uses colonoscopy for screening purposes as much as the United States, although Germany comes close," he noted.
The U.S. Preventive Services Task Force recommends that people 50 to 75 years old be screened for colon cancer in one of three ways: a home fecal occult blood test every year; a sigmoidoscopy every five years combined with a home fecal occult blood test every three years; or a colonoscopy every 10 years.
A colonoscopy examines the inside of the large intestine with a camera-tipped tube. The test enables the physician to remove any precancerous growths -- adenomatous polyps -- which sometimes develop into cancer. Colorectal tumors are a major cause of death from cancer in the United States, with about 137,000 new cases and 52,000 deaths every year, according to the U.S. Centers for Disease Control and Prevention.
For the study, published in the March 5 issue of the Annals of Internal Medicine, the authors reviewed health records of more than 1,000 average-risk adults between the ages of 55 and 85 who were members in four health management organizations (HMOs).
The researchers identified 474 people with late-stage colon cancer and then looked back 10 years to see if they had been screened for the disease with colonoscopy or sigmoidoscopy. They compared them to 538 "control" patients and used additional information from state or local tumor registries to see whether there was an association between having had a colonoscopy or sigmoidoscopy and developing cancer.
Dr. David Bernstein, a gastroenterologist at North Shore University Hospital in Manhasset, N.Y., said the study had a critical design flaw. "Making assumptions that any cancers that were found would have been seen 10 years prior doesn't make sense," he said. "It doesn't prove that these cancers didn't occur two years ago."
A key part of effective colon screening is getting the tests at the recommended interval, experts say. To better understand what might be effective in prodding people to get screening, another study published this month in the same journal found that people who were mailed a letter, a pamphlet and a fecal occult blood test kit completed recommended screening twice as often and for less cost than those who were not reminded or got automated and other reminders by nurse coaches.
Doubeni recommends something far more simple: doing the fecal occult blood test every year right around the time of your birthday.



Do Men Need Earlier Colorectal Screenings?


The Austrian study, published today in the Journal of the American Medical Association, found that men frequently have advanced polyps that could lead to colorectal cancer at ages 45 to 49, a decade earlier than women. These findings have prompted the researchers to conclude that men should likely have their first colonoscopy earlier than 50, the age that current guidelines recommend.
“Our study underlines the results from previous studies on this field, and I hope that now is the time for sex-specific age for referring patients to screening colonoscopy,” researcher Monika Ferlitsch, MD, of the Austrian Society for Gastroenterology and Hepatology in Vienna, writes in an email. “Try to go at age of 45 if you are a man and at age of 50 if you are a woman.”
Not everyone agrees, however. David Bernstein, MD, chief of gastroenterology at North Shore University Hospital in Manhasset, N.Y., says that more research needs to be done before doctors change what they tell their patients. Also, given that the study was conducted in Austria, its results may not apply to American patients.
“Making recommendations based on gender rather than age is something that needs to be explored,” says Bernstein, who was not involved in the research, “but our current screening regimen seems to be impactful for reducing the risk of colorectal cancer.”

Risk Factors Appear in Men 10 to 15 Years Earlier Than in Women

The study, conducted across Austria between 2007 and 2010, included 44,350 people whose average age was 60. A nearly equal number of men and women participated in the study.
Each of them underwent a colonoscopy, a procedure in which a tube-mounted video camera is inserted into the rectum and then snaked through the colon, where it is used to identify cancerous and potentially precancerous growths. Colonoscopies are considered the gold standard tests for detecting colorectal cancer.
Just over 60% of the study participants were given a clean bill of colon health -- no abnormalities were found. Among those whose exams revealed a type of precancerous polyp known as an adenoma, men were much more likely to develop them at a younger age than women. For example, 18.5% of men aged 50 to 54 had adenomas compared to 10.7% of women that age.
It isn’t until women are 65 to 69 years old that their likelihood of adenomas matches men in their early to mid 50s, the researchers note.
According to the study, the likelihood that women have polyps increased as they entered their 60s. For men, a similar increase occurred when they were much younger, between the ages of 45 and 49.
Men were also twice as likely as women to have advanced adenomas, growths that have greater potential to lead to cancer. Overall, men were twice as likely to be diagnosed with colorectal cancer.

Colorectal cancer is the third most common cancer for men and women, according to the American Cancer Society. They estimate that just over 100,000 new cases ofcolon cancer and nearly 40,000 new cases of rectal cancer will be diagnosed this year. In 2011, nearly 50,000 people will die from both cancers combined.
Diagnosing precancerous colon polyps and colorectal cancer at an early stage -- the goal of screening -- vastly improves a patient’s chances of survival. For colorectal surgeon Meagan Costedio, MD, of the Cleveland Clinic, the study results may influence current recommendations on when men should have their first colonoscopy.
“People might be willing to decrease the age to 45 in men and see if it changes things,” says Costedio, who was not involved in the research. “If we see a drop in incidence of cancer, that would be a good change in practice.”
However, she cautions that colonoscopies are not risk-free procedures. Tears, bleeding, and perforations of the colon are rare but possible complications.
“We don’t want to increase the risk of hurting people,” Costedio says.
Another closet corrects the cry.